Paper Details

  1. Home
  2. Paper Details

Chemotherapy for pancreatic cancer.

Author: ArbuckS G

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

No satisfactory treatment exists for advanced pancreatic carcinoma. 5-FU is the only drug with a response rate exceeding 20%, but most responses are partial and short-lived. Combined modality therapy, including radiation and 5-FU, has shown a modest survival advantage, but with increased toxicity and treatment time. The prognosis for pancreatic cancer remains poor, highlighting the need for further research.
Paper Details　
Original Abstract of the Article :
To date, no satisfactory treatment has been developed for treatment of patients with advanced pancreatic carcinoma. The median survival of these patients is only three to six months. Of more than 30 agents evaluated over the past three decades, only 5-FU results in a response rate with 95% confidenc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0950-3528(90)90029-g

データ提供：米国国立医学図書館（NLM）

Pancreatic Cancer: Navigating the Shifting Sands of Treatment

Pancreatic cancer is a formidable adversary, often presenting significant challenges for diagnosis and treatment. This review examines the current state of chemotherapy for pancreatic cancer, exploring the effectiveness of various agents and treatment strategies. The authors provide a comprehensive overview of the challenges and limitations of current treatments, highlighting the need for continued research and development of more effective therapies.

A Difficult Journey: Chemotherapy for Pancreatic Cancer

The review highlights that current chemotherapy options for pancreatic cancer offer limited success, with modest response rates and short-term benefits. [Chemotherapy's limited effectiveness]. The authors emphasize the need for ongoing clinical trials and research to develop more effective treatments for this challenging disease.

A Camel's Perspective on Pancreatic Cancer

Imagine a camel traversing a vast desert, its journey fraught with danger and uncertainty. Pancreatic cancer can be a similar journey, filled with challenges and obstacles. This review explores the current state of chemotherapy for pancreatic cancer, highlighting the difficulties in finding effective treatments for this aggressive disease. Just as a camel needs to be resilient and adapt to the harsh desert environment, researchers are working tirelessly to find new ways to combat pancreatic cancer and improve the lives of those affected by this devastating illness.

Dr. Camel's Conclusion

This review underscores the urgent need for continued research and development of more effective treatments for pancreatic cancer. While current chemotherapy options offer limited benefits, ongoing clinical trials and innovative approaches hold promise for improving outcomes for patients facing this challenging disease.

Date :
  1. Date Completed 1991-04-26
  2. Date Revised 2019-10-29
Further Info :

Pubmed ID

2078794

DOI: Digital Object Identifier

10.1016/0950-3528(90)90029-g

Related Literature

Article Analysis
・Effective treatment of pancreatic cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.